NetworkNewsBreaks – Delic Holdings Corp. (CSE: D
Post# of 135

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has completed the sale of 1,240 units, with each unit consisting of one 4% senior secured $1,064 principal amount convertible debenture and 16,369 share purchase warrants. The sale, which was resulted in gross proceeds of $1,240,000 for the company, was completed on July 27, 2022. According to the announcement, the principal amount and accrued but unpaid interest on each debenture is convertible into common shares of the company; that conversion is done at the option of the holder at any time following the closing date at a price of $0.065 per common share. The company noted that the debentures will mature 24 months from the closing date and will bear interest at a rate of 4% per annum, payable quarterly on the last business day of each calendar quarter. The announcement also noted that all outstanding principal amounts along with all unpaid interest must be repaid at the maturity date. The company also observed that all securities issued in the debenture offering are subject to a hold period of four months and one day from the closing date. Delic intends to use the proceeds from the debenture for expansion and general corporate purposes.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

